4.7 Article

Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+T Cells

期刊

PLOS PATHOGENS
卷 7, 期 10, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1002288

关键词

-

资金

  1. AmFAR Mathilde Krim postdoctoral fellowship
  2. NIH [AI087508]

向作者/读者索取更多资源

Homeostatic proliferation ensures the longevity of central memory T-cells by inducing cell proliferation in the absence of cellular differentiation or activation. This process is governed mainly by IL-7. Central memory T-cells can also be stimulated via engagement of the T-cell receptor, leading to cell proliferation but also activation and differentiation. Using an in vitro model of HIV-1 latency, we have examined in detail the effects of homeostatic proliferation on latently infected central memory T cells. We have also used antigenic stimulation via anti-CD3/anti-CD28 antibodies and established a comparison with a homeostatic proliferation stimulus, to evaluate potential differences in how either treatment affects the dynamics of latent virus populations. First, we show that homeostatic proliferation, as induced by a combination of IL-2 plus IL-7, leads to partial reactivation of latent HIV-1 but is unable to reduce the size of the reservoir in vitro. Second, latently infected cells are able to homeostatically proliferate in the absence of viral reactivation or cell differentiation. These results indicate that IL-2 plus IL-7 may induce a detrimental effect by favoring the maintenance of the latent HIV-1 reservoir. On the other hand, antigenic stimulation efficiently reactivated latent HIV-1 in cultured central memory cells and led to depletion of the latently infected cells via virus-induced cell death.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo

Yanqin Ren, Szu Han Huang, Shabnum Patel, Winiffer D. Conce Alberto, Dean Magat, Dughan Ahimovic, Amanda B. Macedo, Ryan Durga, Dora Chan, Elizabeth Zale, Talia M. Mota, Ronald Truong, Thomas Rohwetter, Chase D. McCann, Colin M. Kovacs, Erika Benko, Avery Wimpelberg, Christopher Cannon, W. David Hardy, Alberto Bosque, Catherine M. Bollard, R. Brad Jones

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Microbiology

Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents

Eric S. Sorensen, Amanda B. Macedo, Rachel S. Resop, J. Natalie Howard, Racheal Nell, Indra Sarabia, Daniel Newman, Yanqin Ren, R. Brad Jones, Vicente Planelles, Adam M. Spivak, Alberto Bosque

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Immunology

Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control

Ashley I. Heinson, Jeongmin Woo, Amey Mukim, Cory H. White, Bastiaan Moesker, Alberto Bosque, Celsa A. Spina, Christopher H. Woelk, Ben D. Macarthur, Nadejda Beliakova-Bethell

Summary: Despite significant progress in identifying cellular factors and pathways contributing to the latent HIV reservoir, the major obstacle to eradicating the virus remains. Noncoding genes, including microRNAs, have been implicated in regulating HIV expression during latency. This study revealed dysregulation of miRNAs in a primary CD4(+) T cell model of HIV latency, with a subset targeting pathways relevant to HIV expression and establishment of latency, such as the p53 signaling pathway.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)

Article Virology

The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary TCM Cell Model of Latency

Indra Sarabia, Szu-Han Huang, Adam R. Ward, R. Brad Jones, Alberto Bosque

Summary: The establishment of HIV-1 latency has posed challenges for curing HIV-1. Current strategies to shock and kill the virus reservoir are not effective in inducing the majority of intact HIV-1 proviruses. The mechanisms behind the non-inducible HIV-1 reservoir still need further investigation.

JOURNAL OF VIROLOGY (2021)

Article Virology

Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs

Yanqin Ren, Szu Han Huang, Amanda B. Macedo, Adam R. Ward, Winiffer D. Conce Alberto, Thais Klevorn, Louise Leyre, Dennis C. Copertino, Talia M. Mota, Dora Chan, Ronald Truong, Thomas Rohwetter, Paul Zumbo, Friederike Dundar, Doron Betel, Colin Kovacs, Erika Benko, Alberto Bosque, R. Brad Jones

Summary: Research has shown that overexpression of BCL-X-L family members in HIV-infected CD4(+) T cells, selective antagonists can induce selective toxicity to these cells, however, the effect on reservoir cells in patients remains limited.

JOURNAL OF VIROLOGY (2021)

Editorial Material Immunology

Editorial: Immunotherapies Towards HIV Cure

Maria Salgado, Alberto Bosque, Carolina Garrido

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Immunology

Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS

Indra Sarabia, Camille L. Novis, Amanda B. Macedo, Hiroshi Takata, Racheal Nell, Juyeon C. Kakazu, Robert L. Furler, Binita Shakya, Heidi L. Schubert, Christopher P. Hill, Ana Beatriz DePaula-Silva, Adam M. Spivak, Lydie Trautmann, Vicente Planelles, Alberto Bosque

Summary: Research has shown that RIG-I agonists require full length-MAVS, while the AOS response induced by Dynasore through its catechol group can reactivate latent HIV-1 in a MAVS dependent manner through miniMAVS isoform. Furthermore, PKC agonists induce an AOS response in CD4 T cells and require miniMAVS to fully reactivate latent HIV-1.

FRONTIERS IN IMMUNOLOGY (2021)

Article Pharmacology & Pharmacy

Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence

E. A. Innis, C. Levinger, M. A. Szaniawski, E. S. C. P. Williams, J. Alcami, A. Bosque, J. T. Schiffer, M. Coiras, A. M. Spivak, V Planelles

Summary: This study investigated FDA-approved oncology drugs and found that dasatinib, ponatinib, and trametinib can significantly reduce proliferation of memory CD4 T cells in HIV-infected individuals. Dasatinib, in particular, blocks both homeostatic and antigen-driven proliferation and aids in reducing the reservoir size. By inhibiting STAT5 phosphorylation, dasatinib hinders IL-7 induced proliferation and prevents spontaneous rebound in cells from people living with HIV-1.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes

Callie Levinger, J. Natalie Howard, Jie Cheng, Pingtao Tang, Amit Joshi, Marta Catalfamo, Alberto Bosque

Summary: The assessment of HIV-1 persistence is challenging, with most commercially available tests focusing on the measurement of nucleic acid. Despite their high sensitivity, these assays have limitations in evaluating translational competent viral reservoirs.

SCIENTIFIC REPORTS (2021)

Correction Multidisciplinary Sciences

An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes (vol 11, 23647, 2021)

Callie Levinger, J. Natalie Howard, Jie Cheng, Pingtao Tang, Amit Joshi, Marta Catalfamo, Alberto Bosque

SCIENTIFIC REPORTS (2021)

Article Virology

Pharmacological Targeting of Sphingosine Kinases Impedes HIV-1 Infection of CD4 T Cells through SAMHD1 Modulation

Rachel S. Resop, Alberto Bosque

Summary: Inhibition of SPHK can reduce HIV-1 transmission between CD4 T cells and decrease susceptibility to infection, which may serve as a basis for developing strategies to prevent HIV-1 infection.

JOURNAL OF VIROLOGY (2022)

Article Virology

The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation

Amanda B. Macedo, Callie Levinger, Bryan N. Nguyen, Jonathan Richard, Mamta Gupta, Conrad Russell Y. Cruz, Andres Finzi, Katherine B. Chiappinelli, Keith A. Crandall, Alberto Bosque

Summary: In this study, we found that HODHBt enhances IL-15 signaling in natural killer cells, leading to increased cytotoxicity and memory-like functions. This suggests that pharmacological enhancement of IL-15-mediated STAT activation could be a new approach for HIV treatment.

JOURNAL OF VIROLOGY (2022)

Article Multidisciplinary Sciences

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells

Eva M. Stevenson, Sandra Terry, Dennis Copertino, Louise Leyre, Ali Danesh, Jared Weiler, Adam R. Ward, Pragya Khadka, Evan McNeil, Kevin Bernard, Itzayana G. Miller, Grant B. Ellsworth, Carrie D. Johnston, Eli J. Finkelsztein, Paul Zumbo, Doron Betel, Friederike Dundar, Maggie C. Duncan, Hope R. Lapointe, Sarah Speckmaier, Nadia Moran-Garcia, Michelle Premazzi Papa, Samuel Nicholes, Carissa J. Stover, Rebecca M. Lynch, Marina Caskey, Christian Gaebler, Tae-Wook Chun, Alberto Bosque, Timothy J. Wilkin, Guinevere Q. Lee, Zabrina L. Brumme, R. Brad Jones

Summary: In a cohort of people with HIV, COVID mRNA vaccination leads to a temporary increase in a specific profile of HIV-specific T-cell responses and a corresponding decrease in residual HIV RNA, indicating productive immune engagement with infected cells.

NATURE COMMUNICATIONS (2022)

Article Biotechnology & Applied Microbiology

PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent

Preethi B. Balakrishnan, Carissa S. Holmberg, Debbie K. Ledezma, Alberto Bosque, Rohan Fernandes

Summary: This study investigates the use of nanoparticles as carriers to deliver drugs for the reactivation of latent HIV infection. The results show that polymeric-coated nanoparticles are more effective than free polymers in activating latent HIV and enhancing immune activation.

NANOMEDICINE (2022)

Review Virology

IL-15 and N-803 for HIV Cure Approaches

J. Natalie Howard, Alberto Bosque

Summary: Despite advances in antiretroviral therapy, the latent reservoir of HIV-infected cells remains a major hurdle in finding a cure. IL-15 and N-803 have shown potential in reactivating latent HIV and enhancing immune effector function, which are crucial for reducing latent reservoirs.

VIRUSES-BASEL (2023)

暂无数据